The Oncology Institute, Inc. TOIIW
Set alert
0.05 USD 0.00 0.00%
As of Aug 3, 11:07 AM ET
0.0474 Day range 0.0474
0.0058 52-week range 0.0094
- YTD
- +0.85%
- 1 year
- +0.85%
- Open
- 0.0474
- Prev close
- 0.0474
- Mkt cap
- 4.67M
- Vol
- 5
- Avg vol
- 0
- EPS
- -602.09
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0474
- High
- 0.0474
- Forward P/E
- 0.00
- Beta
- 0.62
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.00
- 200-d avg
- 0.00
- 1y target
- 0.00
Financial health
Altman Z-Score
0.78 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.2×
FY 2018 5y median -0.2× FY 2025
P/S 0.2×
FY 2018 5y median 0.0× FY 2025
P/B -7.1×
FY 2018 5y median 0.1× FY 2025
P/FCF -4.0×
FY 2018 5y median -0.4× FY 2025
EV/EBITDA -2.4×
FY 2018 5y median -1.4× FY 2025
EV/Sales 0.2×
FY 2018 5y median 0.2× FY 2025
FCF Yield -25.0%
FY 2018 5y median -277.2% FY 2025
Profitability
Gross Margin 13.8%
FY 2018 5y median 18.4% FY 2025
Operating Margin -7.2%
FY 2018 5y median -22.6% FY 2025
Net Margin -12.1%
FY 2018 5y median -12.1% FY 2025
ROE 385.5%
FY 2018 5y median -10.5% FY 2025
ROIC -35.7%
FY 2018 5y median -35.7% FY 2025
ROA -36.8%
FY 2018 5y median -36.8% FY 2025
Growth (YoY)
Revenue 27.8%
FY 2018 FY 2025
Operating Income 40.0%
FY 2018 FY 2025
EPS (diluted) 23.9%
FY 2018 FY 2025
Free Cash Flow 8.4%
FY 2018 FY 2025
Financial Health
Current Ratio 1.6×
FY 2018 5y median 4.1× FY 2025
Quick Ratio 1.4×
FY 2018 5y median 3.7× FY 2025
Debt / Equity -1.7×
FY 2018 5y median 0.9× FY 2025
Net Debt / EBITDA 0.2×
FY 2018 5y median 0.2× FY 2025
Interest Coverage -3.2×
FY 2018 5y median -11.4× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31